Medication vs. Surgery: Lifetime Cost Comparison in PI Damages

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a personal injury plaintiff chooses conservative medication management over surgery, or when surgery is not indicated, the lifetime cost of ongoing pharmacotherapy can equal or exceed surgical intervention costs — a fact that strengthens future damages arguments and reframes medication-based treatment as a legitimate major damages category.

Medication vs. Surgery: Lifetime Cost Comparison in PI Damages

Long-term medication management following a personal injury is not the lesser damages category that defense attorneys and adjusters assume. When a plaintiff requires ongoing pharmacotherapy for chronic pain, neuropathy, post-traumatic migraine, or spasticity that will persist for years or decades, the projected lifetime medication costs represent a substantial damages element that can rival or exceed the cost of surgical intervention — particularly when factoring in the ancillary costs of medication management including monitoring, specialist visits, and periodic medication adjustments.

• Lifetime medication costs for chronic post-traumatic conditions frequently equal or exceed one-time surgical costs when projected over the plaintiff's remaining life expectancy
• Defense attorneys often minimize medication-only treatment plans as "minor" compared to surgery, which misrepresents the actual economic burden
• Future medication cost projections are a legitimate and substantial component of special damages in PI cases
• LienScripts' dispensing records provide the factual foundation for actuarial projections of lifetime medication costs
• As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, a plaintiff's current medication regimen provides the clinical basis for projecting decades of future pharmacotherapy costs

The False Hierarchy of Treatment Costs

There is a persistent assumption in personal injury litigation that surgical treatment represents the highest tier of damages and medication management represents a lower tier. This assumption is clinically and economically incorrect.

Consider a plaintiff with chronic post-traumatic neuropathic pain who is managed with gabapentin, duloxetine, and a topical analgesic. If this regimen must be maintained for thirty years — a reasonable projection for a 35-year-old plaintiff with a permanent nerve injury — the cumulative cost of those three medications, plus the associated quarterly physician visits for prescription management, periodic lab monitoring, and inevitable medication adjustments, constitutes a significant lifetime expense.

Now compare that to a plaintiff who undergoes a single surgical intervention with a defined recovery period. The surgical cost is high but finite. The medication plaintiff's costs compound annually with no end date, creating a damages figure that grows with each year of remaining life expectancy.

Why This Matters for Demand Packages

Attorneys who present medication costs as a minor line item in the demand package are underselling their client's damages. The correct approach is to work with a life care planner or pharmacoeconomics expert to project the plaintiff's current medication regimen forward across their remaining life expectancy, including:

Annual medication costs based on the current regimen, with adjustments for historical drug price inflation rates.

Monitoring costs including regular blood work for medications that require hepatic or renal monitoring, periodic specialist visits for medication management, and pharmacist consultations.

Medication adjustment costs reflecting the clinical reality that chronic medication regimens require periodic changes — dosage adjustments, medication switches due to tolerance or side effects, and additions of new agents as conditions evolve.

Ancillary costs including the impact of medication regimens on employment capacity, driving ability, and daily functioning, which are discussed further in Pill Burden and Daily Medication Schedule as Damages.

The Conservative Treatment Trap

Defense attorneys sometimes argue that a plaintiff who declined surgery in favor of medication management made a choice that limits their damages. This argument fails on multiple grounds.

First, a plaintiff is not obligated to undergo surgery. The legal standard requires reasonable mitigation, not maximum invasiveness. If a physician determined that conservative management was appropriate — or if surgery was not indicated — the plaintiff's choice of medication management is medically reasonable.

Second, as outlined above, the lifetime cost of conservative medication management may actually exceed the one-time surgical cost. The plaintiff's choice of conservative treatment does not reduce their damages — it may increase the present value of their future medical costs.

Building the Future Damages Projection

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. The MERIT report establishes the clinical foundation — which medications the plaintiff requires and why — that a life care planner or economist uses to build the lifetime cost projection.

The current dispensing records from LienScripts serve as the factual baseline: these are the medications the plaintiff actually takes, at these dosages, at this frequency. Projecting that regimen forward with appropriate inflation adjustments produces a defensible future damages figure. For more on how to document future medication costs, see Future Medication Costs: Lifetime Projections in PI.

Practical Takeaway

When evaluating a PI case where the plaintiff is on long-term medication management, do not assume the damages are smaller than a surgical case. Run the numbers. A plaintiff on three chronic medications with thirty years of remaining life expectancy may have future medication costs that represent a six-figure damages component — before accounting for lost productivity, quality of life impacts, and the daily burden of managing a complex medication regimen. For additional context on how medication complexity itself constitutes damages, see Polypharmacy Burden as a Damages Element.

Contact LienScripts to discuss how pharmacy dispensing documentation supports lifetime medication cost projections in your cases.